Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031

Open Extension Study Evaluating The Long Term Efficacy , Safety And Tolerability Of Oral Ziprasidone In The Treatment Of Patients Who Have Successfully Completed The Previous Ziprasidone Study A1281031

Open label extension study of Ziprasidone, evaluation of safety of long term use of ziprasidone

Inclusion Criteria:

• Patients who successfully completed study A1281031 (CGI score of 1 or 2 at final visit) or ZIP-NY-98035 and with QTc <= 500 msec.

Exclusion Criteria:

• All other patients who do not fit the inclusion criteria as stated above.